If TLR4 signaling highlights a survival benefit to tumor cells and alters their sensitivity to Pac, then its silencing via siRNA must aid in identifying the molecular mechanisms responsible for LPS- and Pac-mediated effects. This evidence concerns the gene TLR4 and neoplasm.